SIMABS

Agoralaan, Abis Abis /

3590 Diepenbeek

BE

SIMABS

Foundation date

22/08/2019

Sector

#Biotechnology / R&D Services

Subsector

Therapeutic areas

SIMABS is a start-up biotechnology venture that wants to develop a new bio-manufacturing platform to provide cost effective therapeutic monoclonal antibodies at small scale to biopharmaceutical companies.

Upcoming events

Latest news

  • Latest field trials validate strength of Biotalys’ first biocontrol Evoca

    Thursday May 19th 2022

  • Belgian biotech in European Top-3 despite turbulent times

    Wednesday May 18th 2022

  • KU Leuven announces collaboration and license agreement with Gilead Sciences for the development of new antivirals against the respiratory syncytial virus

    Wednesday May 18th 2022

Jobs by SIMABS